Bxp completes sale of 45% interest in kendall square life sciences property

Boston--(business wire)--bxp (nyse: bxp), the largest publicly traded developer, owner, and manager of premier workplaces in the united states, today announced that it has completed the previously announced sale of a 45% interest in 290 binney street, a life sciences development located in kendall square in cambridge, massachusetts, to norges bank investment management. nbim's investment will reduce bxp's share of the project's estimated development spend over time by approximately $533.5 milli.
BXP Ratings Summary
BXP Quant Ranking